ATC Group: D07AB02 Hydrocortisone butyrate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D07AB02 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D07 Corticosteroids, dermatological preparations
3 D07A Corticosteroids, plain
4 D07AB Corticosteroids, moderately potent (group II)
5 D07AB02 Hydrocortisone butyrate

Active ingredients in D07AB02

Active Ingredient

Hydrocortisone butyrate is the butyrate salt form of hydrocortisone, a synthetic glucocorticoid receptor agonist with antiinflammatory, antipruritic and vasoconstrictive effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2.

Related product monographs

Document Type Information Source  
 LOCOID Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 LOCOID Lotion, 0.1% MPI, US: SPL/PLR FDA, National Drug Code (US)

Medicines in this ATC group

United States (US)

Finland (FI)

France (FR)

Germany (DE)

Ireland (IE)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.